CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
2022 · Journal of Experimental & Clinical Cancer Research · 587 citations
https://doi.org/10.1186/s13046-022-02327-z
Z
Zheng Zhu
Xijing Hospital(CN)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
136
Papers
3.1K
Citations
29
h-index
59
i10-index
Zheng Zhu is an academic researcher from Xijing Hospital. The author has contributed to research in topics: RNA modifications and cancer & Cholangiocarcinoma and Gallbladder Cancer Studies & Cancer Genomics and Diagnostics. The author has an h-index of 29, co-authored 116 publications.
ORCID: 0000-0002-4112-5294Papers by this author
worksParthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
2020 · Cancer Cell International · 40 citations
https://doi.org/10.1186/s12935-020-01658-1
Off-the-shelf CAR–engineered natural killer cells targeting FLT3 enhance killing of acute myeloid leukemia
2023 · Blood Advances · 36 citations
https://doi.org/10.1182/bloodadvances.2022007405
Coupling the near-infrared fluorescent dye IR-780 with cabazitaxel makes renal cell carcinoma chemotherapy possible
2019 · Biomedicine & Pharmacotherapy · 16 citations
https://doi.org/10.1016/j.biopha.2019.109001
Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
2022 · Frontiers in Immunology · 14 citations
https://doi.org/10.3389/fimmu.2022.914612
Determining the molecular landscape and impact on prognosis in HPV-associated head and neck cancer
2020 · Cancers of the Head & Neck · 11 citations
https://doi.org/10.1186/s41199-020-00058-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat